Hexagon Nutrition IPO: Price Band, Dates, and Key Details
- 4th June 2026
- 11:00 AM
- 3 min read
Summary
Hexagon Nutrition Limited's mainboard IPO opens for subscription on 5 June 2026, with a price band of ₹42 to ₹45 per share. The issue is a pure offer for sale of 3.09 crore shares aggregating ₹138.87 crore, with listing on BSE and NSE tentatively scheduled for 12 June 2026.Mumbai | 4June 2026
Hexagon Nutrition Limited, a research-driven nutrition company incorporated in 1993, opens its mainboard initial public offering (IPO) for subscription. The issue closes on 9 June 2026.
Hexagon Nutrition IPO Key Details
| Particulars | Details |
| IPO Date | 5 to 9 June 2026 |
| Listing Date | 12 June 2026 (Tentative) |
| Face Value | ₹1 per share |
| Price Band | ₹42 to ₹45 per share |
| Lot Size | 333 Shares |
| Issue Type | Book Built Issue |
| Sale Type | Offer for Sale (OFS) Only |
| Listing At | BSE, NSE |
What are the Hexagon Nutrition IPO dates and price details?
The IPO is priced between ₹42 and ₹45 per share with a face value of ₹1. The minimum lot size is 333 shares, requiring a retail investment of ₹14,985 at the upper price band. Small non-institutional investors (sNII) must apply for 14 lots (4,662 shares) at ₹2,09,790, while big non-institutional investors (bNII) must apply for 67 lots (22,311 shares) at ₹10,03,995.
Allotment is expected to be finalised on 10 June 2026. Refunds and demat credits are scheduled for 11 June 2026, with listing on BSE and NSE tentatively on 12 June 2026. Cumulative Capital Pvt. Ltd. is the book running lead manager, and KFin Technologies Ltd. is the registrar.
What is the Hexagon Nutrition IPO issue structure?
The issue is entirely an offer for sale of 3,08,59,704 equity shares aggregating up to ₹138.87 crore. No fresh capital will be raised by the company. Pre- and post-issue shareholding remains at 12,29,18,109 shares.
What does Hexagon Nutrition do?
Founded in 1993, Hexagon Nutrition manufactures products across three segments: branded wellness and clinical nutrition (B2C), premix formulations (B2B2C), and ready-to-use foods and micronutrient powders under ESG initiatives. The company operates three manufacturing facilities in India at Nasik, Chennai, and Thoothukudi, and one international unit in Tashkent, Uzbekistan. Its Chennai and Thoothukudi plants are located in SEZ zones.
The company distributes across retail pharmacies, hospital networks, e-commerce platforms, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone, supported by over 358 distributors across India. Between fiscals 2023 and 2025, its products were exported to more than 75 countries across Asia, Africa, Europe, and South America. As of 31 March 2026, the company employed 527 people.
What is the Hexagon Nutrition IPO grey market premium?
The grey market premium (GMP) for the Hexagon Nutrition IPO stood at ₹10 as of 4 June 2026, 09:57 AM, according to Chittorgarh.
Disclaimer: GMP data is sourced from Chittorgarh and is unofficial and unregulated by SEBI. It reflects informal market sentiment only and should not be treated as an indicator of actual listing performance.
Outlook
Subscription will be open from 5 to 9 June 2026. Investors can check allotment status via KFin Technologies at https://ipostatus.kfintech.com/.
For full issue details, visit the Hexagon Nutrition IPO page on PL Capital.
Stay updated on Indian equity and commodity markets. Read more market news on PL Capital.
Disclaimer: Investments in securities market are subject to market risks, read all the related documents carefully before investing.
This is a knowledge-sharing initiative by PL Capital. The information provided is only for educational purposes and should not be considered as financial advice & has no influence on the investment/trading decisions of any investors.
For detailed disclaimers/disclosure and Mandatory terms and conditions please visit our website https://www.plindia.com/regulatory-content/
